Lisa Cabott Carson

Insider Reports History

Reporting-owner location: Westchester, PA
Latest reporting-owner signature: /s/ Lisa C. Carson
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Lisa Cabott Carson

Form 4 holding Chief Financial Officer

Phio Pharmaceuticals Corp.

Security class: Common Stock, $.0001 par value
Shares / value: 189,112
Estimated value: $193,839
Report date: 28 Sep 2026
Price: $1.02
Ownership: Direct

Insider Reports Filed by Lisa Cabott Carson

4 PHIO

Phio Pharmaceuticals Corp.

Report period: 28 Sep 2026
Transactions: 1
Transaction value: $0
Accepted by SEC: 29 Sep 2026, 16:01
Role: Chief Financial Officer
Next action: Open filing details

4 PHIO

Phio Pharmaceuticals Corp.

Report period: 11 Sep 2026
Transactions: 1
Transaction value: $0
Accepted by SEC: 15 Sep 2026, 16:00
Role: Chief Financial Officer
Next action: Open filing details

4 PHIO

Phio Pharmaceuticals Corp.

Report period: 05 Feb 2026
Transactions: 1
Transaction value: $0
Accepted by SEC: 06 Feb 2026, 07:58
Role: Chief Financial Officer
Next action: Open filing details

4 PHIO

Phio Pharmaceuticals Corp.

Report period: 11 Sep 2025
Transactions: 1
Transaction value: $0
Accepted by SEC: 15 Sep 2025, 08:28
Role: VP, Finance and Administration
Next action: Open filing details

3 PHIO

Phio Pharmaceuticals Corp.

Report period: 06 Jun 2025
Transactions: 0
Transaction value: $0
Accepted by SEC: 18 Jun 2025, 16:30
Role: VP, Finance and Administration
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .